Interferon-λ in immunocompetent individuals with a history of recurrent herpes labialis

Antiviral Therapy

Volumn 15, Issue 5, 2010, Pages 737-743

  Pica, Francesca ^a   Volpi, Antonio ^a   Gaziano, Roberta ^a   Garaci, Enrico ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERFERON; LAMBDA INTERFERON; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES LABIALIS; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENCE; ITALY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECURRENT INFECTION; SERODIAGNOSIS; VIRUS PLAQUE;

ADULT; FEMALE; HERPES LABIALIS; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOCOMPETENCE; INTERFERONS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECURRENCE; YOUNG ADULT;

EID: 77957342033     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1610     Document Type: Article

References (52)

1. Whitley RJ. Herpes simplex virus. In Virology. BN Fields, Knipe DM, Chanock RM, et al. (Editors.) New York: Raven Press 1990; pp.1843-1887.
2. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990; 69:19-36.
3. Higgins CR, Schofield JK, Tatnall FM et al. Natural history, management and complications of herpes labialis. J Med Virol 1993; 41 Suppl 1:22-26.
4. Spruance SL, Chou F. Pathogenesis of herpes simplex labialis. J Infect Dis 1980; 142:671-675.
5. Kaufman HE, Centifanto-Fitzgerald YM, Varnell ED. Herpes simplex keratitis. Ophthalmology 1983; 90:700-706.
6. Klieman RL, Green JA, Spruance SL. Immunostimulatory function of herpes simplex virus isolates from patients with frequent herpes labialis and a deficiency in immune specific interferon production. J Med Virol 1985; 16:289-296.
7. Kohl S. Herpes simplex virus immunology: problems, progress and promises. J Infect Dis 1985; 152:435-440. (Pubitemid 15018672)
8. Wildy P, Gell PGH. The host response to herpes simplex virus. Br Med Bull 1985; 41:86-91. (Pubitemid 15165183)
9. Wilton JMA, Ivanyi L, Lehner T. Cell-mediated immunity in herpesvirus hominis infection. BMJ 1972; 1:723-726.
10. O'Reilly RJ, Chibbaro A, Anger E, Lopez C. Cell-mediated immune responses in patients with recurrent herpes simplex infections. J Immunol 1977; 118:1095-1102. (Pubitemid 8070873)
11. Shillitoe EJ, Wilton JMA, Lehner T. Sequential changes in cell-mediate immune responses to herpes simplex virus after recurrent herpetic infection in humans. Infect Immun 1977; 18:130-137.
12. Rattray MC, Peterman GM, Altman LC, Corey L, Holmes KK. Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation. Infect Immun 1980; 30:110-116.
13. Cunningham AL, Merigan TC. Interferon production appears to predict time of recurrence of herpes labialis. J Immunol 1983; 130:2397-2399.
14. Green JA, Weiss PN, Yek TJ, Spruance SL. Immune specific interferon production by peripheral blood mononuclear leukocytes from humans with primary and recurrent orolabial herpes simplex virus infections. J Med Virol 1985; 16:297-305.
15. Sheridan JF, Beck B, Smith CC, Aurelian L. Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro. J Immunol 1987; 138:1234-1239. (Pubitemid 17017912)
16. Kuo YC, Lin CY. Recurrent herpes simplex virus type I infection precipitated by the impaired production of interleukin-2, alpha-interferon, and cell-mediated immunity. J Med Virol 1990; 31:183-189.
17. Spruance SL, Evans TG, McKeough MB, et al. Th1/Th2-like immunity and resistance to herpes simplex labialis. Antiviral Res 1995; 28:39-55.
18. Kotenko SV, Gallagher G, Baurin VV, et al. IFN-λ mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4:69-77. (Pubitemid 36109115)
19. Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29, and their class II cytokine receptor IL-28R. Nat Immunol 2003; 4:63-68.
20. Doyle SE, Schreckhise H, Khuu-Duong K, et al. Interleukin-29 uses a type I interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 2006; 44:896-906.
21. Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells though signaling pathways involving both Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 2007; 81:7749-7758.
22. Marcello T, Grakoui A, Barba-Spaeth G, et al. Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 2006; 131:1887-1898. (Pubitemid 44958521)
23. Robek MD, Boyd BS, Chisari FV. Lambda interferon inhibits hepatitis B and C virus replication. J Virol 2005; 79:3851-3854. (Pubitemid 40327973)
24. Brand S, Beigel F, Olszak T, et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005; 289:G960-G968. (Pubitemid 41532589)
25. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. Lambda-interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against selected virus infection in vivo. J Virol 2006; 80:4501-4509.
26. Hou W, Wang X, Ye L, et al. Lambda interferon inhibits human immunodeficiency virus type I infection of macrophages. J Virol 2009; 83:3834-3842.
27. Contoli M, Message SD, Laza-Stanca V. Role of deficient type III interferon-λ production in asthma exacerbations. Nat Med 2006; 12:1023-1026. (Pubitemid 44353382)
28. La Frazia S, Amici C, Santoro MG. Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection: role of nuclear factor-kappaB. Antivir Ther 2006; 11:995-1004. (Pubitemid 44955175)
29. Volpi A, Stanberry L. Tailoring herpes labialis treatments. Herpes 2007; 14:55.
30. Koelle DM, Corey L. Herpes simplex: insights on/into pathogenesis and possible vaccines. Annu Rev Med 2008; 59:381-395. (Pubitemid 351287944)
31. Seppanen M, Meri S, Notkola I-L, et al. Subtly impaired humoral immunity predispose to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia. J Infect Dis 2006; 194:571-578.
32. Kittan NA, Bergua A, Haupt S, et al. Impaired plasmacytoid dendritic cell innate immune responses in patients with herpes virus-associated acute retinal necrosis. J Immunol 2007; 179:4219-4230.
33. Casrouge A, Zhang S-Y, Eidenschenk C, et al. Herpes simplex encephalitis in human UNC-93B deficiency. Science 2006; 314:308-312.
34. Siegal FP, Kadowaki N, Shoddell M, et al. The nature of the principal type I interferon-producing cells in human blood. Science 1999; 284:1835-1837. (Pubitemid 29291433)
35. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoide monocytes migrate to inflammed lymphnodes and produce large amounts of type I interferon. Nat Med 1999; 5:919-923. (Pubitemid 29372419)
36. Fitzgerald-Bocarsly P. Natural interferon-alpha producing cells: the plasmacytoid dendritic cells. Biotechniques 2002; 33 Suppl 4:S16-S29.
37. Lund J, Sato A, Akira R. Medzhitov, and Iwasaki A. Toll-like receptor 9-mediated recognition of herpes simplex-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198:513-520.
38. Hochrein H, Schlatter B, O'Keeffe M, et al. Herpes simplex virus type-I induces IFN-α production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci U S A 2004; 101:11416-11421. (Pubitemid 39038361)
39. Tabeta K, Hoebe K, Janssen EM, et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 2006; 7:156-164.
40. Zhang S-Y, Jouanguy E, Sancho-Shimizu V, et al. Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol Rev 2007; 220:225-236. (Pubitemid 350045567)
41. Zhang SY, Boisson-Dupuis S, Chapgier A, et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defence. Immunol Rev 2008; 226:29-40.
42. Cunningham AL, Carbone F, Geijtenbeek BH. Langherans cells and viral immunity. Eur J Immunol 2008; 38:2377-2385.
43. Biron CA. Initial and innate responses to viral infections-pattern setting in immunity or disease. Curr Opin Microbiol 1999; 2:374-381.
44. Asselin-Paturel C, Trinchieri G. Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med 2005; 202:461-465. (Pubitemid 41186943)
45. Hansmann L, Groeger S, von Wulffen W, Bein G, Hackstein H. Human monocytes represent a competitive source of interferon-a in peripheral blood. Clin Immunol 2008; 127:252-264.
46. Coccia EM, Severa M, Giacomini E, et al. Viral infection and Toll-like receptor agonists induce a differentiated expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004; 34:796-805.
47. Ank N, Iversen MB, Bartholdy C, et al. An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity. J Immunol 2008; 180:2474-2485.
48. Lasfar A, Lewis-Antes A, Smirnov SV, et al. Characterization of the mouse IFN-λ ligand-receptor system: IFN-λs exhibit antitumor activity against B16 melanoma. Cancer Res 2006; 66:4468-4477.
49. Mennechet FJ, Uze G. Interferon λ-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 2006; 107:4417-4423.
50. Jordan WJ, Eskdale J, Srinivas S, et al. Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response. Genes Immun 2007; 8:254-261. (Pubitemid 46679436)
51. Peng T, Zhu J, Klock A, et al. Evasion of the mucosal innate immune system by herpes simplex virus type 2. J Virol 2009; 83:12559-12568.
52. Milligan GN, Bernstein DI. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 1997; 229:259-268.